Genco Shipping & Trading Limited (NYSE:GNK) announced that it will cut its debt by more than $1 billion by giving control of the company to its lenders in a deal that requires the dry bulk shipping company to file for bankruptcy. Genco Shipping & Trading Limited (NYSE:GNK) shares after opening at $1.54 moved to $2.91 on last trade day and at the end of the day closed at $1.94. Company price to sales ratio in past twelve months was calculated as 0.44 and price to cash ratio as 0.79. Genco Shipping & Trading Limited (NYSE:GNK) showed a positive weekly performance of 14.79%.
Galena Biopharma (NASDAQ:GALE), a biopharmaceutical company developing and commercializing innovative, targeted oncology treatments that address major unmet medical needs to advance cancer care, announced that Mark J. Ahn, Ph.D., President and Chief Executive Officer will present a corporate update at the 13th Annual Needham Healthcare Conference. The presentation will take place on Tuesday, April 8, 2014 at 8:40 a.m. ET at the Westin Grand Central Hotel in New York, NY. Galena Biopharma Inc. (NASDAQ:GALE) shares fell -4.20% in last trading session and ended the day on $2.28. GALE return on equity ratio is recorded as -435.40% and its return on assets is -113.60%. Galena Biopharma Inc. (NASDAQ:GALE) yearly performance is 10.68%.
YOU On Demand Holdings, Inc.(NASDAQ:YOD) a leading multi-platform entertainment and Video On Demand company inChina, on 4 april announced the expansion of its cooperation to offer feature films from global film and television studio,Miramax, via YOU On Demand’s mobile service. You On Demand Holdings, Inc. (NASDAQ:YOD) shares moved up 0.74% in last trading session and was closed at $4.09, while trading in range of $3.90 – $4.57. You On Demand Holdings, Inc. (NASDAQ:YOD) year to date (YTD) performance is 80.97%.
Synthetic Biologics Inc. (NYSEMKT:SYN) on Mar. 31 reported financial results for the year ended December 31, 2013 and provided operational highlights. Synthetic Biologics Inc. (NYSEMKT:SYN) weekly performance is -11.41%. On last trading day company shares ended up $2.33. Synthetic Biologics Inc. (NYSEMKT:SYN) distance from 50-day simple moving average (SMA50) is -7.84%. Analysts mean target price for the company is $3.94.
Leave a Reply